Clinical trial

Hormonal Birth Control and the Risk of Acquiring HIV

NCT00006324

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Ethinyl estradiol/levonorgestrel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Medroxyprogesterone acetate Normalized identity: medroxyprogesterone acetateView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Hormonal Birth Control and the Risk of Acquiring HIV

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1999-12-01

PhaseNA

Conditions

HIV Infectionsunresolved

Interventions

Ethinyl estradiol/levonorgestrelDRUG

Medroxyprogesterone acetateDRUG · verified · RxNorm: medroxyprogesterone acetate

Sponsors & collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)lead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006324 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.